Inigo Narvaiza - Publications

Salk Institute for Biological Studies, La Jolla, CA, United States 
Brain mosaicism

29 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Marchetto MC, Hrvoj-Mihic B, Kerman BE, Yu DX, Vadodaria KC, Linker SB, Narvaiza I, Santos R, Denli AM, Mendes AP, Oefner R, Cook J, McHenry L, Grasmick JM, Heard K, et al. Species-specific maturation profiles of human, chimpanzee and bonobo neural cells. Elife. 8. PMID 30730291 DOI: 10.7554/eLife.37527  1
2017 Linker SB, Marchetto MC, Narvaiza I, Denli AM, Gage FH. Examining non-LTR retrotransposons in the context of the evolving primate brain. Bmc Biology. 15: 68. PMID 28800766 DOI: 10.1186/s12915-017-0409-z  1
2017 Franks TM, Benner C, Narvaiza I, Marchetto MCN, Young JM, Malik HS, Gage FH, Hetzer MW. Corrigendum: Evolution of a transcriptional regulator from a transmembrane nucleoporin. Genes & Development. 31: 845. PMID 28512238 DOI: 10.1101/gad.300699.117  1
2016 Nuttle X, Giannuzzi G, Duyzend MH, Schraiber JG, Narvaiza I, Sudmant PH, Penn O, Chiatante G, Malig M, Huddleston J, Benner C, Camponeschi F, Ciofi-Baffoni S, Stessman HA, Marchetto MC, et al. Emergence of a Homo sapiens-specific gene family and chromosome 16p11.2 CNV susceptibility. Nature. PMID 27487209 DOI: 10.1038/nature19075  1
2016 Franks TM, Benner C, Narvaiza I, Marchetto MC, Young JM, Malik HS, Gage FH, Hetzer MW. Evolution of a transcriptional regulator from a transmembrane nucleoporin. Genes & Development. PMID 27198230 DOI: 10.1101/gad.280941.116  1
2015 Denli AM, Narvaiza I, Kerman BE, Pena M, Benner C, Marchetto MC, Diedrich JK, Aslanian A, Ma J, Moresco JJ, Moore L, Hunter T, Saghatelian A, Gage FH. Primate-Specific ORF0 Contributes to Retrotransposon-Mediated Diversity. Cell. 163: 583-93. PMID 26496605 DOI: 10.1016/j.cell.2015.09.025  1
2015 Prescott SL, Srinivasan R, Marchetto MC, Grishina I, Narvaiza I, Selleri L, Gage FH, Swigut T, Wysocka J. Enhancer Divergence and cis-Regulatory Evolution in the Human and Chimp Neural Crest. Cell. 163: 68-83. PMID 26365491 DOI: 10.1016/j.cell.2015.08.036  1
2014 Richardson SR, Narvaiza I, Planegger RA, Weitzman MD, Moran JV. APOBEC3A deaminates transiently exposed single-strand DNA during LINE-1 retrotransposition. Elife. 3: e02008. PMID 24843014 DOI: 10.7554/eLife.02008  1
2013 Marchetto MC, Narvaiza I, Denli AM, Benner C, Lazzarini TA, Nathanson JL, Paquola AC, Desai KN, Herai RH, Weitzman MD, Yeo GW, Muotri AR, Gage FH. Differential L1 regulation in pluripotent stem cells of humans and apes. Nature. 503: 525-9. PMID 24153179 DOI: 10.1038/nature12686  1
2012 Narvaiza I, Landry S, Weitzman MD. APOBEC3 proteins and genomic stability: the high cost of a good defense. Cell Cycle (Georgetown, Tex.). 11: 33-8. PMID 22157092 DOI: 10.4161/cc.11.1.18706  1
2011 Landry S, Narvaiza I, Linfesty DC, Weitzman MD. APOBEC3A can activate the DNA damage response and cause cell-cycle arrest. Embo Reports. 12: 444-50. PMID 21460793 DOI: 10.1038/embor.2011.46  1
2011 Bulliard Y, Narvaiza I, Bertero A, Peddi S, Röhrig UF, Ortiz M, Zoete V, Castro-Díaz N, Turelli P, Telenti A, Michielin O, Weitzman MD, Trono D. Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities. Journal of Virology. 85: 1765-76. PMID 21123384 DOI: 10.1128/JVI.01651-10  1
2009 Narvaiza I, Linfesty DC, Greener BN, Hakata Y, Pintel DJ, Logue E, Landau NR, Weitzman MD. Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase. Plos Pathogens. 5: e1000439. PMID 19461882 DOI: 10.1371/journal.ppat.1000439  1
2007 Barajas M, Franchi F, Clavel C, Aranguren XL, Kramer MG, Abizanda G, Merino J, Moreno C, Gárate L, Guitart A, Narvaiza I, Gutiérrez-Perez M, Riezu-Boj JI, Berasain C, Prieto J, et al. Multipotent Adult Progenitor Cells (MAPC) contribute to hepatocarcinoma neovasculature. Biochemical and Biophysical Research Communications. 364: 92-9. PMID 17931602 DOI: 10.1016/j.bbrc.2007.09.106  1
2007 Iannacone M, Sitia G, Narvaiza I, Ruggeri ZM, Guidotti LG. Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus. Clinical and Vaccine Immunology : Cvi. 14: 1532-5. PMID 17881509 DOI: 10.1128/CVI.00298-07  1
2006 Narvaiza I, Aparicio O, Vera M, Razquin N, Bortolanza S, Prieto J, Fortes P. Effect of adenovirus-mediated RNA interference on endogenous microRNAs in a mouse model of multidrug resistance protein 2 gene silencing. Journal of Virology. 80: 12236-47. PMID 17020948 DOI: 10.1128/JVI.01205-06  1
2006 Chen H, Lilley CE, Yu Q, Lee DV, Chou J, Narvaiza I, Landau NR, Weitzman MD. APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons. Current Biology : Cb. 16: 480-5. PMID 16527742 DOI: 10.1016/j.cub.2006.01.031  1
2006 Aparicio O, Razquin N, Zaratiegui M, Narvaiza I, Fortes P. Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production. Journal of Virology. 80: 1376-84. PMID 16415015 DOI: 10.1128/JVI.80.3.1376-1384.2006  1
2003 Mazzolini G, Narvaiza I, Martinez-Cruz LA, Arina A, Barajas M, Galofré JC, Qian C, Mato JM, Prieto J, Melero I. Pancreatic cancer escape variants that evade immunogene therapy through loss of sensitivity to IFNgamma-induced apoptosis. Gene Therapy. 10: 1067-78. PMID 12808437 DOI: 10.1038/  1
2003 Narvaiza I, Mazzolini G, Qian C, Prieto J, Melero I. First generation adenoviral vectors, the vector par excellence for immuno-gene therapy of cancer | Vectores adenovirales de primera generación, el vector por excelencia en inmunoterapia génica del cáncer Inmunologia. 22: 225-242.  1
2002 Schmitz V, Qian C, Ruiz J, Sangro B, Melero I, Mazzolini G, Narvaiza I, Prieto J. Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignancies. Gut. 50: 130-5. PMID 11772981 DOI: 10.1136/gut.0500130..  1
2001 Prieto J, Qian C, Melero I, Sangro B, Mazzolini G, Narvaiza I, Barajas M. Gene therapy of primary and metastatic liver tumors. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 7: 76-7. PMID 12211755  1
2001 Mazzolini G, Narvaiza I, Bustos M, Duarte M, Tirapu I, Bilbao R, Qian C, Prieto J, Melero I. Alpha(v)beta(3) integrin-mediated adenoviral transfer of interleukin-12 at the periphery of hepatic colon cancer metastases induces VCAM-1 expression and T-cell recruitment. Molecular Therapy : the Journal of the American Society of Gene Therapy. 3: 665-72. PMID 11356071 DOI: 10.1006/mthe.2001.0317  1
2001 Mazzolini G, Narvaiza I, Pérez-Diez A, Rodriguez-Calvillo M, Qian C, Sangro B, Ruiz J, Prieto J, Melero I. Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12. Gene Therapy. 8: 259-67. PMID 11313799 DOI: 10.1038/  1
2001 Melero I, Mazzolini G, Narvaiza I, Qian C, Chen L, Prieto J. IL-12 gene therapy for cancer: in synergy with other immunotherapies. Trends in Immunology. 22: 113-5. PMID 11286714 DOI: 10.1016/S1471-4906(00)01824-X  1
2001 Barajas M, Mazzolini G, Genové G, Bilbao R, Narvaiza I, Schmitz V, Sangro B, Melero I, Qian C, Prieto J. Gene therapy of orthotopic hepatocellular carcinoma in rats using adenovirus coding for interleukin 12. Hepatology (Baltimore, Md.). 33: 52-61. PMID 11124820 DOI: 10.1053/jhep.2001.20796  1
2000 Zaratiegui M, Narvaiza I, Qian C, Novo FJ. Method to decrease the titers of contaminating helper adenovirus during the production of recombinant adeno-associated virus. Biotechniques. 28: 1096, 1098, 1100. PMID 10868274  1
2000 Narvaiza I, Mazzolini G, Barajas M, Duarte M, Zaratiegui M, Qian C, Melero I, Prieto J. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy. Journal of Immunology (Baltimore, Md. : 1950). 164: 3112-22. PMID 10706701  1
2000 Mazzolini G, Qian C, Narvaiza I, Barajas M, Borrás-Cuesta F, Xie X, Duarte M, Melero I, Prieto J. Adenoviral gene transfer of interleukin 12 into tumors synergizes with adoptive T cell therapy both at the induction and effector level. Human Gene Therapy. 11: 113-25. PMID 10646644 DOI: 10.1089/10430340050016201  1
Show low-probability matches.